Sign in

or Register now

MyBreastCancerNetwork.com

See all of our health sites at www.HealthCentral.com
Wednesday, November, 11, 2009
  • Font size
  • Bookmark
  • Save

Our Breast Cancer Experts

EXPERT
Kevin Knopf, MD

Kevin Knopf, MD

(Profile)
Medical Oncologist
posted 03/18/2009, comments (4)

When Even the Experts Disagree…Who Benefits from Adjuvant Chemotherapy

Data presented at the San Antonio Breast Cancer Symposium show that basically all women with HER2+ breast cancers benefit from adjuvant chemotherapy/Herceptin due to their worse prognosis. In my mind, however, there is no more controversial area in breast cancer than in which patients truly benefit from receiving adjuvant chemotherapy, among women... Read moreChevron
EXPERT
Luis A. Diaz, MD

Luis A. Diaz, MD

(Profile)
Professor, Johns Hopkins
posted 06/04/2007, comments (0)

A Doctor's Read on the New Chemo Brain Treatment Study

Chemo brain, also known as cognitive impairment from chemotherapy, is a term frequently used by breast cancer patients and survivors to describe memory slips and general brain fog thought to be an after-effect of chemotherapy. In recent months, chemo brain has achieved a level of validation, at least in the realm of academic research and... Read moreChevron
EXPERT
Alvaro Pereira-Rico, MD

Alvaro Pereira-Rico, MD

(Profile)
Medical Oncologist
posted 05/18/2007, comments (0)

Medical Oncologist's Response to Luteinizing Hormone-Releasing Hormone (LH-RH) Agonist Study

Breast Cancer News Editor's Note: Science and health news outlet EurekAlert! published yesterday an interesting summary of a Lancet study on luteinizing hormone-releasing hormone (LH-RH) agonists, drugs that decrease the level of estrogen and other sex hormones in women.  LH-RH agonists for breast cancer treatment are used in... Read moreChevron
  • Font size
  • Bookmark
  • Save

Ask a Question

Get answers from our experts and community members.

View all questions (3833) >